Osteoporosis International

, Volume 14, Supplement 5, pp 118–127

Bone quality: where do we go from here?

  • Mary L. Bouxsein
Original Article

Abstract

As was true 10 years ago, tremendous interest surrounds the concept of "bone quality," as shown by the intense and growing research activity in the field. The urgency to advance knowledge in this area is motivated by the need to understand not only the causes of increased skeletal fragility with aging and disease, but also the mechanisms by which drugs reduce fracture risk. As reflected in the preceding articles, in the past decade collaborations between biologists, physicists, engineers and clinicians have led to new insights regarding the biological, material and structural features that contribute to skeletal fragility. Despite these new insights, important issues remain unresolved. Our challenges lie in identifying, describing and understanding the totality of features and characteristics that determine a bone's ability to resist fracture, and using this information to identify new therapeutic targets and develop better biomarkers and noninvasive imaging modalities. This summary is intended to integrate reports in the literature with presentations and discussions that occurred during the meeting, to highlight areas of consensus and those of continued controversy, and thus to identify critical areas for future research.

References

  1. 1.
    Currey JD (2003) Role of collagen and other organics in the mechanical properties of bone. Osteoporos Int 14:tbdGoogle Scholar
  2. 2.
    Jepsen K (2003) The aging cortex: to crack or not to crack. Osteoporos Int 14:tbdGoogle Scholar
  3. 3.
    Currey JD (2001) Bone strength: what are we trying to measure? Calcif Tissue Int 68:205–210PubMedGoogle Scholar
  4. 4.
    Meunier PJ, Boivin G (1997) Bone mineral density reflects bone mass but also the degree of mineralization of bone: therapeutic implications. Bone 21:373–377CrossRefPubMedGoogle Scholar
  5. 5.
    Currey JD (1999) What determines the bending strength of compact bone? J Exp Biol 202:2495–2503PubMedGoogle Scholar
  6. 6.
    Currey JD (1969) The mechanical consequences of variation in the mineral content of bone. J Biomech 2:1–11Google Scholar
  7. 7.
    Boivin GY, Chavassieux PM, Santora AC, Yates J, Meunier PJ (2000) Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone 27:687–694Google Scholar
  8. 8.
    Roschger P, Rinnerthaler S, Yates J, et al (2001) Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone 29:185–191CrossRefPubMedGoogle Scholar
  9. 9.
    Cranney A, Wells G, Willan A, et al (2002) Meta-analysis of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 23:508–516CrossRefPubMedGoogle Scholar
  10. 10.
    Misof BM, Roschger P, Cosman F, et al (2003) Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab 88:1150–1156CrossRefPubMedGoogle Scholar
  11. 11.
    Neer RM, Arnaud CD, Zanchetta JR, et al (2001) Effect of parathyroid hormone (1–34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434–1441PubMedGoogle Scholar
  12. 12.
    van der Linden JC, Homminga J, Verhaar JA, Weinans H (2001) Mechanical consequences of bone loss in cancellous bone. J Bone Miner Res 16:457–465PubMedGoogle Scholar
  13. 13.
    Yeh OC, Keaveny TM (2001) Relative roles of microdamage and microfracture in the mechanical behavior of trabecular bone. J Orthop Res 19:1001–1007CrossRefPubMedGoogle Scholar
  14. 14.
    Boskey AL (2003) Bone mineral crystal size. Osteoporos Int 14:tbdGoogle Scholar
  15. 15.
    Zioupos P, Currey JD, Hamer AJ (1999) The role of collagen in the declining mechanical properties of aging human cortical bone. J Biomed Mater Res 45:108–116CrossRefPubMedGoogle Scholar
  16. 16.
    Burr D (2002) The contribution of the organic matrix to the bone's material properties. Bone 31:8–11CrossRefPubMedGoogle Scholar
  17. 17.
    Gao H, Ji B, Jager IL, Arzt E, Fratzl P (2003) Materials become insensitive to flaws at nanoscale: lessons from nature. Proc Natl Acad Sci USA 100:5597–5600CrossRefPubMedGoogle Scholar
  18. 18.
    Mann V, Hobson EE, Li B, et al (2001) A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 107:899–907PubMedGoogle Scholar
  19. 19.
    Efstathiadou Z, Tsatsoulis A, Ioannidis JP (2001) Association of collagen Ialpha 1 Sp1 polymorphism with the risk of prevalent fractures: a meta-analysis. J Bone Miner Res 16:1586–1592PubMedGoogle Scholar
  20. 20.
    Garnero P, Cloos P, Sornay-Rendu E, Qvist P, Delmas PD (2002) Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study. J Bone Miner Res 17:826–833PubMedGoogle Scholar
  21. 21.
    Gundberg C (2003) Matrix proteins. Osteoporos Int 14:tbdGoogle Scholar
  22. 22.
    Zioupos P (1999) On microcracks, microcracking, in-vivo, in vitro, in-situ and other issues. J Biomech 32:209–211, 13–59CrossRefPubMedGoogle Scholar
  23. 23.
    Parfitt AM (2002) Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone 30:5–7CrossRefPubMedGoogle Scholar
  24. 24.
    Burr DB (2002) Targeted and nontargeted remodeling. Bone 30:2–4CrossRefPubMedGoogle Scholar
  25. 25.
    Schaffler MB (2003) Role of bone turnover in microdamage. Osteoporos Int 14:tbdGoogle Scholar
  26. 26.
    Mashiba T, Hirano T, Turner CH, et al (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15:613–620PubMedGoogle Scholar
  27. 27.
    Mashiba T, Turner CH, Hirano T, et al (2001) Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 28:524–531CrossRefPubMedGoogle Scholar
  28. 28.
    Komatsubara S, Mori S, Mashiba T, et al (2003) Long-term treatment of incadronate disodium accumulates microdamage but improves the trabecular bone microarchitecture in dog vertebra. J Bone Miner Res 18:512–520PubMedGoogle Scholar
  29. 29.
    Tonino RP, Meunier PJ, Emkey R, et al (2000) Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group. J Clin Endocrinol Metab 85:3109–3115Google Scholar
  30. 30.
    Sorensen OH, Crawford GM, Mulder H, et al (2003) Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience. Bone 32:120–126CrossRefPubMedGoogle Scholar
  31. 31.
    Vashishth D, Behiri JC, Bonfield W (1997) Crack growth resistance in cortical bone: concept of microcrack toughening. J Biomech 30:763–769CrossRefPubMedGoogle Scholar
  32. 32.
    Zioupos P (1998) Recent developments in the study of failure of solid biomaterials and bone: 'fracture' and 'prefracture' toughness. Mat Sci Eng 6Google Scholar
  33. 33.
    Vashishth D, Tanner KE, Bonfield W (2003) Experimental validation of a microcracking-based toughening mechanism for cortical bone. J Biomech 36:121–124CrossRefPubMedGoogle Scholar
  34. 34.
    Burr DB (2003) Microdamage and bone strength. Osteoporos Int 14:tbdGoogle Scholar
  35. 35.
    Ciarelli TE, Fyhrie DP, Parfitt AM (2003) Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females. Bone 32:311–315CrossRefPubMedGoogle Scholar
  36. 36.
    Lanyon L, Skerry T (2001) Postmenopausal osteoporosis as a failure of bone's adaptation to functional loading: a hypothesis. J Bone Miner Res 16:1937–1947PubMedGoogle Scholar
  37. 37.
    Ciarelli TE, Fyhrie DP, Schaffler MB, Goldstein SA (2000) Variations in three-dimensional cancellous bone architecture of the proximal femur in female hip fractures and in controls. J Bone Miner Res 15:32–40PubMedGoogle Scholar
  38. 38.
    Yeh OC, Keaveny TM (1999) Biomechanical effects of intraspecimen variations in trabecular architecture: a three-dimensional finite element study. Bone 25:223–228CrossRefPubMedGoogle Scholar
  39. 39.
    Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312:1254–1259PubMedGoogle Scholar
  40. 40.
    Cummings SR, Bates D, Black DM (2002) Clinical use of bone densitometry: scientific review. JAMA 288:1889–1897CrossRefPubMedGoogle Scholar
  41. 41.
    Garnero P (2000) Markers of bone turnover for the prediction of fracture risk. Osteoporos Int 11 [Suppl 6]:S55–65Google Scholar
  42. 42.
    Garnero P, Delmas P (2001) Biochemical markers of bone turnover in osteoporosis. In: Marcus R, Kelsey J, Feldman D (eds) Osteoporosis. Academic Press, San Diego, pp 459–478Google Scholar
  43. 43.
    Eastell R, Barton I, Hannon RA, et al (2003) Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res 18:1051–1056PubMedGoogle Scholar
  44. 44.
    Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J (2000) The use of biochemical markers of bone turnover in osteoporosis. Committee of scientific advisors of the International Osteoporosis Foundation. Osteoporos Int 11:S2–17CrossRefPubMedGoogle Scholar
  45. 45.
    Johnell O, Oden A, De Laet C, et al (2002) Biochemical indices of bone turnover and the assessment of fracture probability. Osteoporos Int 13:523–526CrossRefGoogle Scholar
  46. 46.
    Riggs BL, Melton LJ 3rd (2002) Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density. J Bone Miner Res 17:11–14PubMedGoogle Scholar
  47. 47.
    Beck TJ (2003) Measuring the structural strength of bones with dual-energy X-ray absorptiometry: principles, technical limitations, and future possibilities. Osteoporos Int 14:tbdGoogle Scholar
  48. 48.
    Muller R (2003) Bone microarchitecture assessment—current and future trends. Osteoporos Int 14:tbdGoogle Scholar
  49. 49.
    Dempster D (2003) Bone microarchitecture and strength. Osteoporos Int 14:tbdGoogle Scholar
  50. 50.
    Beck TJ, Oreskovic TL, Stone KL, et al (2001) Structural adaptation to changing skeletal load in the progression toward hip fragility: the study of osteoporotic fractures. J Bone Miner Res 16:1108–1119PubMedGoogle Scholar
  51. 51.
    Beck TJ, Stone KL, Oreskovic TL, et al (2001) Effects of current and discontinued estrogen replacement therapy on hip structural geometry: the study of osteoporotic fractures. J Bone Miner Res 16:2103–2110PubMedGoogle Scholar
  52. 52.
    Beck TJ, Looker AC, Ruff CB, Sievanen H, Wahner HW (2000) Structural trends in the aging femoral neck and proximal shaft: analysis of the Third National Health and Nutrition Examination Survey dual-energy X-ray absorptiometry data. J Bone Miner Res 15:2297–2304PubMedGoogle Scholar
  53. 53.
    Crabtree N, Lunt M, Holt G, et al (2000) Hip geometry, bone mineral distribution, and bone strength in European men and women: the EPOS study. Bone 27:151–159CrossRefPubMedGoogle Scholar
  54. 54.
    Nelson DA, Barondess DA, Hendrix SL, Beck TJ (2000) Cross-sectional geometry, bone strength, and bone mass in the proximal femur in black and white postmenopausal women. J Bone Miner Res 15:1992–1997PubMedGoogle Scholar
  55. 55.
    Crabtree NJ, Kroger H, Martin A, et al (2002) Improving risk assessment: hip geometry, bone mineral distribution and bone strength in hip fracture cases and controls. The EPOS study. European Prospective Osteoporosis Study. Osteoporos Int 13:48–54CrossRefGoogle Scholar
  56. 56.
    Looker AC, Beck TJ, Orwoll ES (2001) Does body size account for gender differences in femur bone density and geometry? J Bone Miner Res 16:1291–1299Google Scholar
  57. 57.
    Link TM, Majumdar S, Grampp S, et al (1999) Imaging of trabecular bone structure in osteoporosis. Eur Radiol 9:1781–1788PubMedGoogle Scholar
  58. 58.
    Wehrli FW, Saha PK, Gomberg BR, et al (2002) Role of magnetic resonance for assessing structure and function of trabecular bone. Top Magn Reson Imaging 13:335–355CrossRefPubMedGoogle Scholar
  59. 59.
    Wehrli FW, Hilaire L, Fernandez-Seara M, et al (2002) Quantitative magnetic resonance imaging in the calcaneus and femur of women with varying degrees of osteopenia and vertebral deformity status. J Bone Miner Res 17:2265–2273PubMedGoogle Scholar
  60. 60.
    Link TM, Majumdar S, Augat P, et al (1998) Proximal femur: assessment for osteoporosis with T2* decay characteristics at MR imaging. Radiology 209:531–536PubMedGoogle Scholar
  61. 61.
    Brismar TB (2000) MR relaxometry of lumbar spine, hip, and calcaneus in healthy premenopausal women: relationship with dual energy X-ray absorptiometry and quantitative ultrasound. Eur Radiol 10:1215–1221CrossRefPubMedGoogle Scholar
  62. 62.
    Link TM, Vieth V, Stehling C, et al (2003) High-resolution MRI vs multislice spiral CT: which technique depicts the trabecular bone structure best? Eur Radiol 13:663–671PubMedGoogle Scholar
  63. 63.
    Majumdar S, Genant HK, Grampp S, et al (1997) Correlation of trabecular bone structure with age, bone mineral density, and osteoporotic status: in vivo studies in the distal radius using high resolution magnetic resonance imaging. J Bone Miner Res 12:111–118PubMedGoogle Scholar
  64. 64.
    Wehrli FW, Hwang SN, Ma J, et al (1998) Cancellous bone volume and structure in the forearm: noninvasive assessment with MR microimaging and image processing. Radiology 206:347–357PubMedGoogle Scholar
  65. 65.
    Link TM, Majumdar S, Augat P, et al (1998) In vivo high resolution MRI of the calcaneus: differences in trabecular structure in osteoporosis patients. J Bone Miner Res 13:1175–1182PubMedGoogle Scholar
  66. 66.
    Wehrli FW, Gomberg BR, Saha PK, et al (2001) Digital topological analysis of in vivo magnetic resonance microimages of trabecular bone reveals structural implications of osteoporosis. J Bone Miner Res 16:1520–1531PubMedGoogle Scholar
  67. 67.
    Link TM, Vieth V, Matheis J, et al (2002) Bone structure of the distal radius and the calcaneus vs BMD of the spine and proximal femur in the prediction of osteoporotic spine fractures. Eur Radiol 12:401–408PubMedGoogle Scholar
  68. 68.
    Majumdar S, Link TM, Augat P, et al (1999) Trabecular bone architecture in the distal radius using magnetic resonance imaging in subjects with fractures of the proximal femur. Magnetic Resonance Science Center and Osteoporosis and Arthritis Research Group. Osteoporos Int 10:231–239PubMedGoogle Scholar
  69. 69.
    Lang TF, Li J, Harris ST, Genant HK (1999) Assessment of vertebral bone mineral density using volumetric quantitative CT. J Comput Assist Tomogr 23:130–137CrossRefPubMedGoogle Scholar
  70. 70.
    Lang TF, Guglielmi G, van Kuijk C, et al (2002) Measurement of bone mineral density at the spine and proximal femur by volumetric quantitative computed tomography and dual-energy X-ray absorptiometry in elderly women with and without vertebral fractures. Bone 30:247–250CrossRefPubMedGoogle Scholar
  71. 71.
    Lane NE, Sanchez S, Modin GW, et al (1998) Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial. J Clin Invest 102:1627–1633PubMedGoogle Scholar
  72. 72.
    Lane NE, Sanchez S, Modin GW, et al (2000) Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial. J Bone Miner Res 15:944–951PubMedGoogle Scholar
  73. 73.
    Rehman Q, Lang T, Modin G, Lane NE (2002) Quantitative computed tomography of the lumbar spine, not dual X-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy. Arthritis Rheum 46:1292–1297CrossRefPubMedGoogle Scholar
  74. 74.
    Rehman Q, Lang TF, Arnaud CD, Modin GW, Lane NE (2003) Daily treatment with parathyroid hormone is associated with an increase in vertebral cross-sectional area in postmenopausal women with glucocorticoid-induced osteoporosis. Osteoporos Int 14:77–81PubMedGoogle Scholar
  75. 75.
    Ahlborg HG, Johnell O, Nilsson BE, et al (2001) Bone loss in relation to menopause: a prospective study during 16 years. Bone 28:327–331CrossRefPubMedGoogle Scholar
  76. 76.
    Chevalier F, Laval-Jeantet AM, Laval-Jeantet M, Bergot C (1992) CT image analysis of the vertebral trabecular network in vivo. Calcif Tissue Int 51:8–13PubMedGoogle Scholar
  77. 77.
    Ito M, Ohki M, Hayashi K, et al (1995) Trabecular texture analysis of CT images in the relationship with spinal fracture. Radiology 194:55–59PubMedGoogle Scholar
  78. 78.
    Pistoia W, van Rietbergen B, Laib A, Ruegsegger P (2001) High-resolution three-dimensional-pQCT images can be an adequate basis for in-vivo microFE analysis of bone. J Biomech Eng 123:176–183CrossRefPubMedGoogle Scholar
  79. 79.
    van Rietbergen B, Majumdar S, Newitt D, MacDonald BR (2002) High-resolution MRI and micro-FE for the evaluation of changes in bone mechanical properties during longitudinal clinical trials: application to calcaneal bone in postmenopausal women after 1 year of idoxifene treatment. Clin Biomech (Bristol, Avon) 17:81–88Google Scholar
  80. 80.
    Newitt DC, van Rietbergen B, Majumdar S (2002) Processing and analysis of in vivo high-resolution MR images of trabecular bone for longitudinal studies: reproducibility of structural measures and micro-finite element analysis derived mechanical properties. Osteoporos Int 13:278–287CrossRefGoogle Scholar
  81. 81.
    Newitt DC, Majumdar S, van Rietbergen B, et al (2002) In vivo assessment of architecture and micro-finite element analysis derived indices of mechanical properties of trabecular bone in the radius. Osteoporos Int 13:6–17CrossRefGoogle Scholar
  82. 82.
    Brandenburger G (1993) Clinical determination of bone quality: Is ultrasound an answer? Calif Tissue Int 53:S151–S156Google Scholar
  83. 83.
    Gluer CC (1997) Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. The International Quantitative Ultrasound Consensus Group. J Bone Miner Res 12:1280–1288PubMedGoogle Scholar
  84. 84.
    Hans D, Dargent-Molina P, Schott AM, et al (1996) Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 348:511–514PubMedGoogle Scholar
  85. 85.
    Bauer DC, Gluer CC, Cauley JA, et al (1997) Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study of the Osteoporotic Fractures Research Group. Arch Intern Med 157:629–634PubMedGoogle Scholar
  86. 86.
    Wear KA (2003) Characterization of trabecular bone using the backscattered spectral centroid shift. IEEE Trans Ultrason Ferroelectr Freq Control 50:402–407CrossRefPubMedGoogle Scholar
  87. 87.
    Chaffai S, Peyrin F, Nuzzo S, et al (2002) Ultrasonic characterization of human cancellous bone using transmission and backscatter measurements: relationships to density and microstructure. Bone 30:229–237CrossRefPubMedGoogle Scholar
  88. 88.
    Jenson F, Padilla F, Laugier P (2003) Prediction of frequency-dependent ultrasonic backscatter in cancellous bone using statistical weak scattering model. Ultrasound Med Biol 29:455–464CrossRefPubMedGoogle Scholar
  89. 89.
    Ouedraogo E, Lasaygues P, Lefebvre JP, et al (2002) Contrast and velocity ultrasonic tomography of long bones. Ultrason Imaging 24:139–160PubMedGoogle Scholar
  90. 90.
    Padilla F, Peyrin F, Laugier P (2003) Prediction of backscatter coefficient in trabecular bones using a numerical model of three-dimensional microstructure. J Acoust Soc Am 113:1122–1129CrossRefPubMedGoogle Scholar
  91. 91.
    Wear KA (2001) Fundamental precision limitations for measurements of frequency dependence of backscatter: applications in tissue-mimicking phantoms and trabecular bone. J Acoust Soc Am 110:3275–3282.CrossRefPubMedGoogle Scholar
  92. 92.
    Wear KA, Armstrong DW 3rd (2001) Relationships among calcaneal backscatter, attenuation, sound speed, hip bone mineral density, and age in normal adult women. J Acoust Soc Am 110:573–578CrossRefPubMedGoogle Scholar
  93. 93.
    Wu Y, Ackerman JL, Chesler DA, et al (2003) Density of organic matrix of native mineralized bone measured by water- and fat-suppressed proton projection MRI. Magn Reson Med 50:59–68CrossRefPubMedGoogle Scholar
  94. 94.
    Wu Y, Ackerman JL, Strawich ES, et al (2003) Phosphate ions in bone: identification of a calcium-organic phosphate complex by 31P solid-state NMR spectroscopy at early stages of mineralization. Calcif Tissue Int 72:610–626PubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2003

Authors and Affiliations

  • Mary L. Bouxsein

There are no affiliations available

Personalised recommendations